{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,29]],"date-time":"2025-09-29T00:14:10Z","timestamp":1759104850748,"version":"3.37.3"},"reference-count":36,"publisher":"Springer Science and Business Media LLC","issue":"9","license":[{"start":{"date-parts":[[2023,7,14]],"date-time":"2023-07-14T00:00:00Z","timestamp":1689292800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2023,7,14]],"date-time":"2023-07-14T00:00:00Z","timestamp":1689292800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Ann Hematol"],"published-print":{"date-parts":[[2023,9]]},"DOI":"10.1007\/s00277-023-05365-5","type":"journal-article","created":{"date-parts":[[2023,7,14]],"date-time":"2023-07-14T08:02:01Z","timestamp":1689321721000},"page":"2329-2342","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Age-related differences in risks and outcomes of 30-day readmission in adults with sickle cell disease"],"prefix":"10.1007","volume":"102","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-3215-8657","authenticated-orcid":false,"given":"Ming","family":"Chen","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kenneth I.","family":"Ataga","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jane S.","family":"Hankins","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Min","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Justin D.","family":"Gatwood","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jim Y.","family":"Wan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"James E.","family":"Bailey","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2023,7,14]]},"reference":[{"key":"5365_CR1","unstructured":"CDC (2022) Data & Statistics on Sickle Cell Disease. In: Cent. Dis. Control Prev. https:\/\/www.cdc.gov\/ncbddd\/sicklecell\/data.html. Accessed 13 Feb 2023"},{"key":"5365_CR2","doi-asserted-by":"publisher","first-page":"721","DOI":"10.1016\/j.amjmed.2003.07.011","volume":"115","author":"KI Ataga","year":"2003","unstructured":"Ataga KI, Orringer EP (2003) Hypercoagulability in sickle cell disease: a curious paradox. Am J Med 115:721\u2013728. https:\/\/doi.org\/10.1016\/j.amjmed.2003.07.011","journal-title":"Am J Med"},{"key":"5365_CR3","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1111\/j.1365-2141.2007.06740.x","volume":"139","author":"KI Ataga","year":"2007","unstructured":"Ataga KI, Cappellini MD, Rachmilewitz EA (2007) \u03b2-Thalassaemia and sickle cell anaemia as paradigms of hypercoagulability. Br J Haematol 139:3\u201313. https:\/\/doi.org\/10.1111\/j.1365-2141.2007.06740.x","journal-title":"Br J Haematol"},{"key":"5365_CR4","doi-asserted-by":"publisher","unstructured":"Ataga KI, Key NS (2007) Hypercoagulability in sickle cell disease: new approaches to an old problem. Hematol Am Soc Hematol Educ Program 91\u201396. doi: https:\/\/doi.org\/10.1182\/asheducation-2007.1.91","DOI":"10.1182\/asheducation-2007.1.91"},{"key":"5365_CR5","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1002\/ajh.20336","volume":"79","author":"SK Ballas","year":"2005","unstructured":"Ballas SK, Lusardi M (2005) Hospital readmission for adult acute sickle cell painful episodes: frequency, etiology, and prognostic significance. Am J Hematol 79:17\u201325. https:\/\/doi.org\/10.1002\/ajh.20336","journal-title":"Am J Hematol"},{"key":"5365_CR6","unstructured":"Characteristics of Inpatient Hospital Stays Involving Sickle Cell Disease, 2000\u20132016 #251. https:\/\/www.hcup-us.ahrq.gov\/reports\/statbriefs\/sb251-Sickle-Cell-Disease-Stays-2016.jsp. Accessed 13 Feb 2023"},{"key":"5365_CR7","doi-asserted-by":"publisher","first-page":"1288","DOI":"10.1001\/jama.2010.378","volume":"303","author":"DC Brousseau","year":"2010","unstructured":"Brousseau DC, Owens PL, Mosso AL et al (2010) Acute Care Utilization and Rehospitalizations for Sickle Cell Disease. JAMA 303:1288\u20131294. https:\/\/doi.org\/10.1001\/jama.2010.378","journal-title":"JAMA"},{"key":"5365_CR8","unstructured":"Center for Medicare and Medicaid Services (CMS) (2022) CMS Hospital Readmissions Reduction Program. https:\/\/www.cms.gov\/Medicare\/Medicare-Fee-for-Service-Payment\/AcuteInpatientPPS\/Readmissions-Reduction-Program. Accessed 6 Feb 2023"},{"key":"5365_CR9","doi-asserted-by":"publisher","first-page":"601.e9","DOI":"10.1016\/j.amjmed.2016.12.010","volume":"130","author":"MA Brodsky","year":"2017","unstructured":"Brodsky MA, Rodeghier M, Sanger M et al (2017) Risk factors for 30-day readmission in adults with sickle cell disease. Am J Med 130:601.e9-601.e15. https:\/\/doi.org\/10.1016\/j.amjmed.2016.12.010","journal-title":"Am J Med"},{"key":"5365_CR10","doi-asserted-by":"publisher","first-page":"365","DOI":"10.1177\/1358863X18768685","volume":"23","author":"M Chen","year":"2018","unstructured":"Chen M, Goodin A, Xiao H et al (2018) Hospitalization metrics associated with hospital-level variation in inferior vena cava filter utilization for patients with venous thromboembolism in the United States: Implications for quality of care. Vasc Med 23:365\u2013371. https:\/\/doi.org\/10.1177\/1358863X18768685","journal-title":"Vasc Med"},{"key":"5365_CR11","doi-asserted-by":"publisher","first-page":"406","DOI":"10.1002\/pbc.23140","volume":"58","author":"J Leschke","year":"2012","unstructured":"Leschke J, Panepinto JA, Nimmer M et al (2012) Outpatient follow-up and rehospitalizations for sickle cell disease patients. Pediatr Blood Cancer 58:406\u2013409. https:\/\/doi.org\/10.1002\/pbc.23140","journal-title":"Pediatr Blood Cancer"},{"key":"5365_CR12","doi-asserted-by":"publisher","first-page":"554","DOI":"10.1182\/blood.V114.22.554.554","volume":"114","author":"C Haywood","year":"2009","unstructured":"Haywood C, Lanzkron S (2009) The burden of hospital readmissions for patients with sickle cell disease in California and North Carolina: 2004 to 2007. Blood 114:554. https:\/\/doi.org\/10.1182\/blood.V114.22.554.554","journal-title":"Blood"},{"key":"5365_CR13","doi-asserted-by":"publisher","first-page":"2082","DOI":"10.1038\/s41598-020-58934-3","volume":"10","author":"V Kumar","year":"2020","unstructured":"Kumar V, Chaudhary N, Achebe MM (2020) Epidemiology and predictors of all-cause 30-Day readmission in patients with sickle cell crisis. Sci Rep 10:2082. https:\/\/doi.org\/10.1038\/s41598-020-58934-3","journal-title":"Sci Rep"},{"key":"5365_CR14","unstructured":"UpToDate (2023) Red blood cell transfusion in sickle cell disease: Indications and transfusion techniques. https:\/\/www.uptodate.com\/contents\/red-blood-cell-transfusion-in-sickle-cell-disease-indications-and-transfusion-techniques. Accessed 22 June 2023"},{"key":"5365_CR15","doi-asserted-by":"publisher","first-page":"2331","DOI":"10.1111\/trf.13155","volume":"55","author":"M Nouraie","year":"2015","unstructured":"Nouraie M, Gordeuk VR (2015) Blood transfusion and 30-day readmission rate in adult patients hospitalized with sickle cell disease crisis. Transfusion (Paris) 55:2331\u20132338. https:\/\/doi.org\/10.1111\/trf.13155","journal-title":"Transfusion (Paris)"},{"key":"5365_CR16","doi-asserted-by":"publisher","first-page":"930","DOI":"10.1016\/S0140-6736(12)61726-7","volume":"381","author":"J Howard","year":"2013","unstructured":"Howard J, Malfroy M, Llewelyn C et al (2013) The transfusion alternatives preoperatively in sickle cell disease (TAPS) study: a randomised, controlled, multicentre clinical trial. Lancet 381:930\u2013938. https:\/\/doi.org\/10.1016\/S0140-6736(12)61726-7","journal-title":"Lancet"},{"key":"5365_CR17","unstructured":"Agency for Healthcare Research and Quality (2018) The HCUP Nationwide Readmissions Database (NRD), 2016. https:\/\/www.hcup-us.ahrq.gov\/db\/nation\/nrd\/Introduction_NRD_2010-2016.jsp#elements. Accessed 6 Feb 2023"},{"key":"5365_CR18","unstructured":"Agency for Healthcare Research and Quality (2022) HCUP-US Cost-to-Charge Ratio for Inpatient Files. https:\/\/hcup-us.ahrq.gov\/db\/ccr\/ip-ccr\/ip-ccr.jsp. Accessed 24 Apr 2023"},{"key":"5365_CR19","doi-asserted-by":"publisher","first-page":"1130","DOI":"10.1097\/01.mlr.0000182534.19832.83","volume":"43","author":"H Quan","year":"2005","unstructured":"Quan H, Sundararajan V, Halfon P et al (2005) Coding algorithms for defining comorbidities in ICD-9-CM and ICD-10 administrative data. Med Care 43:1130\u20131139. https:\/\/doi.org\/10.1097\/01.mlr.0000182534.19832.83","journal-title":"Med Care"},{"key":"5365_CR20","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1177\/08901171211024426","volume":"36","author":"M Chen","year":"2022","unstructured":"Chen M, Surbhi S, Bailey JE (2022) Association of weight loss with type 2 diabetes remission among adults in medically underserved areas: a retrospective cohort study. Am J Health Promot 36:29\u201337. https:\/\/doi.org\/10.1177\/08901171211024426","journal-title":"Am J Health Promot"},{"key":"5365_CR21","unstructured":"UpToDate (2022) Acute chest syndrome (ACS) in sickle cell disease (adults and children). https:\/\/www.uptodate.com\/contents\/acute-chest-syndrome-acs-in-sickle-cell-disease-adults-and-children. Accessed 16 Feb 2023"},{"key":"5365_CR22","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1002\/ajh.21968","volume":"86","author":"SD Candrilli","year":"2011","unstructured":"Candrilli SD, O\u2019Brien SH, Ware RE et al (2011) Hydroxyurea adherence and associated outcomes among Medicaid enrollees with sickle cell disease. Am J Hematol 86:273\u2013277. https:\/\/doi.org\/10.1002\/ajh.21968","journal-title":"Am J Hematol"},{"key":"5365_CR23","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1586\/ehm.10.22","volume":"3","author":"AM Brandow","year":"2010","unstructured":"Brandow AM, Panepinto JA (2010) Hydroxyurea use in sickle cell disease: the battle with low prescription rates, poor patient compliance and fears of toxicities. Expert Rev Hematol 3:255\u2013260. https:\/\/doi.org\/10.1586\/ehm.10.22","journal-title":"Expert Rev Hematol"},{"key":"5365_CR24","doi-asserted-by":"publisher","first-page":"828","DOI":"10.1002\/pbc.24459","volume":"60","author":"MA Blinder","year":"2013","unstructured":"Blinder MA, Vekeman F, Sasane M et al (2013) Age-related treatment patterns in sickle cell disease patients and the associated sickle cell complications and healthcare costs. Pediatr Blood Cancer 60:828\u2013835. https:\/\/doi.org\/10.1002\/pbc.24459","journal-title":"Pediatr Blood Cancer"},{"key":"5365_CR25","doi-asserted-by":"publisher","first-page":"E30","DOI":"10.1002\/ajh.24953","volume":"93","author":"VG Nolan","year":"2018","unstructured":"Nolan VG, Anderson SM, Smeltzer MP et al (2018) Pediatric to adult care co-location transitional model for youth with sickle cell disease. Am J Hematol 93:E30\u2013E32. https:\/\/doi.org\/10.1002\/ajh.24953","journal-title":"Am J Hematol"},{"key":"5365_CR26","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1080\/16078454.2018.1549801","volume":"24","author":"RM Cronin","year":"2019","unstructured":"Cronin RM, Hankins JS, Byrd J et al (2019) Risk factors for hospitalizations and readmissions among individuals with sickle cell disease: results of a U.S. survey study. Hematology 24:189\u2013198. https:\/\/doi.org\/10.1080\/16078454.2018.1549801","journal-title":"Hematology"},{"key":"5365_CR27","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1080\/16078454.2020.1780737","volume":"25","author":"RM Cronin","year":"2020","unstructured":"Cronin RM, Yang M, Hankins JS et al (2020) Association between hospital admissions and healthcare provider communication for individuals with sickle cell disease. Hematology 25:229\u2013240. https:\/\/doi.org\/10.1080\/16078454.2020.1780737","journal-title":"Hematology"},{"key":"5365_CR28","doi-asserted-by":"publisher","first-page":"e29209","DOI":"10.1002\/pbc.29209","volume":"68","author":"KE Howell","year":"2021","unstructured":"Howell KE, Saulsberry-Abate AC, Mathias JG et al (2021) Transition care continuity promotes long-term retention in adult care among young adults with sickle cell disease. Pediatr Blood Cancer 68:e29209. https:\/\/doi.org\/10.1002\/pbc.29209","journal-title":"Pediatr Blood Cancer"},{"key":"5365_CR29","doi-asserted-by":"publisher","first-page":"2497","DOI":"10.1007\/s00277-020-04233-w","volume":"99","author":"RJ Desai","year":"2020","unstructured":"Desai RJ, Mahesri M, Globe D et al (2020) Clinical outcomes and healthcare utilization in patients with sickle cell disease: a nationwide cohort study of Medicaid beneficiaries. Ann Hematol 99:2497\u20132505. https:\/\/doi.org\/10.1007\/s00277-020-04233-w","journal-title":"Ann Hematol"},{"key":"5365_CR30","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1186\/s12913-021-07461-6","volume":"22","author":"C Lobo","year":"2022","unstructured":"Lobo C, Moura P, Fidlarczyk D et al (2022) Cost analysis of acute care resource utilization among individuals with sickle cell disease in a middle-income country. BMC Health Serv Res 22:42. https:\/\/doi.org\/10.1186\/s12913-021-07461-6","journal-title":"BMC Health Serv Res"},{"key":"5365_CR31","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1007\/s00277-015-2558-x","volume":"95","author":"S Inoue","year":"2016","unstructured":"Inoue S, Khan I, Mushtaq R et al (2016) Pain management trend of vaso-occulsive crisis (VOC) at a community hospital emergency department (ED) for patients with sickle cell disease. Ann Hematol 95:221\u2013225. https:\/\/doi.org\/10.1007\/s00277-015-2558-x","journal-title":"Ann Hematol"},{"key":"5365_CR32","first-page":"1050","volume":"102","author":"CM Jenerette","year":"2010","unstructured":"Jenerette CM, Brewer C (2010) Health-Related Stigma in Young Adults With Sickle Cell Disease. J Natl Med Assoc 102:1050\u20131055","journal-title":"J Natl Med Assoc"},{"key":"5365_CR33","doi-asserted-by":"publisher","first-page":"1081","DOI":"10.1080\/01612840500280745","volume":"26","author":"C Jenerette","year":"2005","unstructured":"Jenerette C, Funk M, Murdaugh C (2005) Sickle cell disease: a stigmatizing condition that may lead to depression. Issues Ment Health Nurs 26:1081\u20131101. https:\/\/doi.org\/10.1080\/01612840500280745","journal-title":"Issues Ment Health Nurs"},{"key":"5365_CR34","doi-asserted-by":"publisher","first-page":"683","DOI":"10.1080\/10245332.2018.1457200","volume":"23","author":"RM Cronin","year":"2018","unstructured":"Cronin RM, Hankins JS, Byrd J et al (2018) Modifying factors of the health belief model associated with missed clinic appointments among individuals with sickle cell disease. Hematology 23:683\u2013691. https:\/\/doi.org\/10.1080\/10245332.2018.1457200","journal-title":"Hematology"},{"key":"5365_CR35","doi-asserted-by":"publisher","first-page":"e10940","DOI":"10.2196\/10940","volume":"20","author":"SM Badawy","year":"2018","unstructured":"Badawy SM, Cronin RM, Hankins J et al (2018) Patient-centered eHealth interventions for children, adolescents, and adults with sickle cell disease: systematic review. J Med Internet Res 20:e10940. https:\/\/doi.org\/10.2196\/10940","journal-title":"J Med Internet Res"},{"key":"5365_CR36","doi-asserted-by":"publisher","first-page":"429","DOI":"10.1056\/NEJMoa1611770","volume":"376","author":"KI Ataga","year":"2017","unstructured":"Ataga KI, Kutlar A, Kanter J et al (2017) Crizanlizumab for the prevention of pain crises in sickle cell disease. N Engl J Med 376:429\u2013439. https:\/\/doi.org\/10.1056\/NEJMoa1611770","journal-title":"N Engl J Med"}],"container-title":["Annals of Hematology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00277-023-05365-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00277-023-05365-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00277-023-05365-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,8,22]],"date-time":"2023-08-22T12:10:45Z","timestamp":1692706245000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00277-023-05365-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,7,14]]},"references-count":36,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2023,9]]}},"alternative-id":["5365"],"URL":"https:\/\/doi.org\/10.1007\/s00277-023-05365-5","relation":{},"ISSN":["0939-5555","1432-0584"],"issn-type":[{"type":"print","value":"0939-5555"},{"type":"electronic","value":"1432-0584"}],"subject":[],"published":{"date-parts":[[2023,7,14]]},"assertion":[{"value":"9 May 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 July 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 July 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This article does not contain any studies with human participants or animals performed by any of the authors.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"The authors declare that they have no conflict of interest.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}